EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Exploring the Evolution of Leiomyomatosis Peritonealis Disseminata: A Longitudinal Study on Malignant Transformation and Potential Biomarkers

Ciera Danen, Esha Aneja, Anushka Gupta, Catherine Mayer, Rohit Sharma

Clinical Medicine & Research · 2025

DOI: 10.3121/cmr.2025.1978 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Medicine & Research, 2025. Verfasst von Ciera Danen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Cell Transformation, Neoplastic, Leiomyomatosis, Peritoneal Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Leiomyomatosis peritonealis disseminate (LPD) is an entity with uncertain biological behavior, characterized by multiple smooth muscle intra-abdominal and pelvic nodules that may recur after apparently complete resection. LPD has been predominantly described in childbearing age females. Most case reports with short term follow-up describe this as a benign entity. Only isolated case reports indicate the malignant potential of the disease. A comprehensive collation of cases is lacking in literature.

Methods

We present a case of malignant transformation of LPD, confirmed by histology and imaging, occurring over two decades. This patient was originally diagnosed with uterine atypical smooth muscle tumor but developed frank malignancy during follow-up. An increasingly malignant aggressive disease course resulted in ultimate development of liver and lung metastases almost 23 years after original diagnoses, resulting in her demise. A comprehensive literature review was performed, and 213 cases of LPD were described, including the present case. Patients were divided into G1 (reportedly benign), G2 (malignant at presentation), and G3 (malignant transformation).

Results

Compared to G1, G2 at presentation were more likely to be symptomatic (73%/88%), larger sized (4.1/8.4 cm), and older aged (38/44). In G1, G2, and G3, the average age was 38.5, 44.3, and 37.5 years, respectively; while the disease specific survival was 100%, 71%, and 40%, respectively. The mean number of surgeries performed in G1, G2, and G3 was 1.6, 1.8, and 3.8, respectively. Hormone receptors were found in 24.4% of cases. The mean reported follow-up time in G1, G2, and G3, respectively, was 44.9, 13.1, and 70.5 months. This suggests with longer follow-up, even apparently benign tumors may develop malignancy. The transformation time to malignancy in G3 was 77.8 months, which is more than the average reported follow-up in G1 (44.9 months).

Conclusions

LPD is a potentially malignant condition with long latency prior to transformation. Lifelong surveillance should be considered even in cases originally presumed to be benign. Loss of hormone receptor expression may serve as a marker for this transformation. Circulating Tumor DNA (ctDNA) levels may be associated with development of hematogenous metastases and may be a useful biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCell Transformation, NeoplasticLeiomyomatosisPeritoneal NeoplasmsUterine NeoplasmsFemaleHumansLongitudinal StudiesFatal Outcome

Stichwörter der Autor:innen

ER/PRLMSLPDLeiomyomatosis peritonealis disseminateLeiomyosarcomactDNA

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • California Northstate University College of Medicine, Elk Grove, California, USA.
  • Tufts University, School of Arts and Science, Medford, MA, USA.
  • Department of General Surgery, Marshfield Medical Center, Marshfield, Wisconsin, USA.
  • Department of General Surgery, Marshfield Medical Center, Marshfield, Wisconsin, USA sharma.rohit@marshfieldclinic.org.

Zitieren

APA

Danen, C., Aneja, E., Gupta, A., Mayer, C., & Sharma, R. (2025). Exploring the Evolution of Leiomyomatosis Peritonealis Disseminata: A Longitudinal Study on Malignant Transformation and Potential Biomarkers. Clinical Medicine & Research. https://doi.org/10.3121/cmr.2025.1978

Vancouver

Danen C, Aneja E, Gupta A, Mayer C, Sharma R. Exploring the Evolution of Leiomyomatosis Peritonealis Disseminata: A Longitudinal Study on Malignant Transformation and Potential Biomarkers. Clinical Medicine & Research. 2025. doi:10.3121/cmr.2025.1978

BibTeX
@article{Danen2025,
  author = {Danen, Ciera and Aneja, Esha and Gupta, Anushka and Mayer, Catherine and Sharma, Rohit},
  title = {Exploring the Evolution of Leiomyomatosis Peritonealis Disseminata: A Longitudinal Study on Malignant Transformation and Potential Biomarkers},
  journal = {Clinical Medicine & Research},
  year = {2025},
  doi = {10.3121/cmr.2025.1978}
}
Kostenlos starten →